Clinical Trial Update: Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a triple combination of regorafenib, ipilimumab, and nivolumab in chemotherapy-resistant microsatellite-stable metastatic colo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Opdivo (nivolumab) (nivolumab)
• Stivarga (regorafenib) (regorafenib)
• Yervoy (Ipilimumab) (Ipilimumab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Advanced Colon Adenocarcinoma, Metastatic Colon Adenocarcinoma | Phase 1 | Status: COMPLETED